Nome Químico: (S)-2-(1-(2-(7-Bromo-2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
Sorrisos: O=C(N)C(C1=CC=CC=C1)([C@H]2CN(CCC3=CC(Br)=C(OCC4)C4=C3)CC2)C5=CC=CC=C5
Inchi: InChI=1S/C28H31BrN2O2/c29-16-13-22-19-21(11-12-26(22)32)14-17-31-18-15-25(20-31)28(27(30)33,23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-12,19,25,32H,13-18,20H2,(H2,30,33)/t25-/m1/s1
Identification, isolation and characterization of dimer impurities in antimuscarinic agent darifenacin hydrobromide
By Gupta, P. Badarinadh; Rao, B. Venkateswara; Douglas, S. Paul; Sharma, Hemant Kumar; Bharathi, D. Vijaya
From World Journal of Pharmaceutical Research (2017), 6(6), 1041-1063
Development and validation of HPLC method for determination of potential genotoxic impurities in darifenacin hydrobromide drug substance
By Patcha, Vinay Kumar; Gajbhiye, Susheela Bhai; Vundavilli, Jagadeesh Kumar; Kothapalli, S. R. Pavan Kumar; Sreenivas, N.; Ray, U. K.
From International Journal of Pharmacy and Pharmaceutical Research (2017), 8(2), 198-208
Development and validation of a stability-indicating RP-HPLC method for determination of darifenacin hydrobromide in bulk drugs
By Nazeerunnisa, Mohammed; Garikapati, Lakshmi; Bethanabhatla, Syama Sundar
From American Journal of Analytical Chemistry (2014), 5(17), 1239-1248